Author

Evan L. Dray

University of Wisconsin–MadisonORCID 0000-0002-9293-7583Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Aicha E. QuamineiD· 1 shared Anastasia A Griggs· 1 shared Bryon D. JohnsoniD· 1 shared Chloe A King· 1 shared Christian M. CapitiniiD· 1 shared Jillian M Kline· 1 shared Katharine E. TippinsiD· 1 shared Lei ShiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aicha E. QuamineORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplant

Aicha E. Quamine, Evan L. Dray, Nicholas R Mohrdieck, Chloe A King, Anastasia A Griggs, Jillian M Kline, Monica M. Cho, S. P. Rinella, Katharine E. Tippins, Paul D. Bates, Lei Shi, Longzhen Song, Nicholas J Hess, Tyce J. Kearl, Bryon D. Johnson, Christian M. Capitini

This study shows that combining TIM-3 blockade with ex vivo stimulated allogeneic NK cells improves survival and reduces tumor growth in a murine neuroblastoma model after allo-HCT without increasing GVHD.

Journal for ImmunoTherapy of Cancer · Dec 1, 2025Peer-reviewedImmunology